|
|
Relief Therapeutics Holding SA / Key words: Personnel
Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives
08May2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Miscellaneous
Relief Therapeutics has published its Annual Report
30Apr2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Therapeutics has published its Annual Report... Lire le communiqué |
|
|
|
| |
|
| |
|
|
Relief Therapeutics Holding SA
/ Key words: AGMEGM
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
26.04.2024 / 17:30 CET/CEST
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting of Shareholders Shareholders approved all proposals by a large... Lire le communiqué |
|
|
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: AGMEGM
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
27March2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary... Lire le communiqué |
|
|
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Partnership
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
22March2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Financing
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
28Feb2024 / 06:45 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Therapeutics Renews CHF 50 million Share Sub... Lire le communiqué |
|
|
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Miscellaneous
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
05Dec2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
| |
|
| |
